This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE RASH (rash at injection site), VACCINATION SITE PRURITUS (injection site was itchy), VACCINATION SITE PAIN (pain at injection site), PYREXIA (evening fever) and FEELING COLD (felt really cold) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 043B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. The patient's past medical history included Anxiety since an unknown date and Hypertension since an unknown date. Concomitant products included CITALOPRAM for Anxiety, LOSARTAN POTASSIUM and TERAZOSIN for Hypertension, LEVOTHYROXINE SODIUM (SYNTHROID) and METOPROLOL for an unknown indication. On 17-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Apr-2021, the patient experienced VACCINATION SITE RASH (rash at injection site), VACCINATION SITE PRURITUS (injection site was itchy) and VACCINATION SITE PAIN (pain at injection site). On 27-Apr-2021, the patient experienced PYREXIA (evening fever) and FEELING COLD (felt really cold). On 28-Apr-2021, the patient experienced SARS-COV-2 TEST POSITIVE (tested positive for COVID-19). At the time of the report, VACCINATION SITE RASH (rash at injection site), VACCINATION SITE PRURITUS (injection site was itchy), VACCINATION SITE PAIN (pain at injection site), PYREXIA (evening fever), FEELING COLD (felt really cold) and SARS-COV-2 TEST POSITIVE (tested positive for COVID-19) outcome was unknown. Not Provided. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 28-Apr-2021, SARS-CoV-2 test positive: Positive. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route), the reporter did not provide any causality assessments. Patient received treatment Benadryl and Tylenol. NO additional information was reported. This case was linked to US-MODERNATX, INC.-MOD-2021-101850 (E2B Linked Report). This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 03-May-2021 and was forwarded to Moderna on 03-May-2021\. This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE RASH (rash at injection site), VACCINATION SITE PRURITUS (injection site was itchy), VACCINATION SITE PAIN (pain at injection site), PYREXIA (evening fever) and FEELING COLD (felt really cold) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 043B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. The patient's past medical history included Anxiety since an unknown date and Hypertension since an unknown date. Concomitant products included CITALOPRAM for Anxiety, LOSARTAN POTASSIUM and TERAZOSIN for Hypertension, LEVOTHYROXINE SODIUM (SYNTHROID) and METOPROLOL for an unknown indication. On 17-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Apr-2021, the patient experienced VACCINATION SITE RASH (rash at injection site), VACCINATION SITE PRURITUS (injection site was itchy) and VACCINATION SITE PAIN (pain at injection site). On 27-Apr-2021, the patient experienced PYREXIA (evening fever) and FEELING COLD (felt really cold). On 28-Apr-2021, the patient experienced SARS-COV-2 TEST POSITIVE (tested positive for COVID-19). At the time of the report, VACCINATION SITE RASH (rash at injection site), VACCINATION SITE PRURITUS (injection site was itchy), VACCINATION SITE PAIN (pain at injection site), PYREXIA (evening fever), FEELING COLD (felt really cold) and SARS-COV-2 TEST POSITIVE (tested positive for COVID-19) outcome was unknown. Not Provided DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 28-Apr-2021, SARS-CoV-2 test positive: Positive. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route), the reporter did not provide any causality assessments. Patient received treatment Benadryl and Tylenol. NO additional information was reported.  This case was linked to US-MODERNATX, INC.-MOD-2021-101850 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-101850:crosslinked case.